Alzheimer; News from the web:
A team at Duke University in North Carolina observed that with Alzheimer’s, immune cells that normally protect the brain instead begin to consume a vital nutrient called arginine.
By blocking this process with a drug, they were able to prevent the formation of “plaques” in the brain that are characteristic of Alzheimer’s disease, and also halted memory loss in the mice.
Read all about it HERE
Alzheimer; News from the web:
The hope that Alzheimer’s will one day be curable has in recent yearsfaded to a flicker as successive clinical trials ended in failure. But the prospect of a treatment this week grew a little brighter as scientists uncovered a new and unexpected explanation for the development of the disease.
Read all about it HERE
Alzheimer; News from the web:
Women who find it difficult to think and move at the same time, an ability required to perform everyday tasks such as driving a car are at a higher risk of contracting Alzheimer’s disease, suggests a new study.
The researchers at York University in Canada found a link between performance in such tasks and a communication problem between different brain regions that promote simultaneous thinking and moving.
The study, focused on women, was published in the Journal of Alzheimer’s Disease.
Read all about it HERE
Alzheimer; News from the web:
Another article about the claimed miracle diet to prevent Alzheimer called DASH. This time a more practical guide with what foods to eat and to avoid and what to make for dinner.
Read all about it HERE
Alzheimer; News from the web:
More news on the great trial from Biogen:
A new Alzheimer’s drug that reverses the damage the disease causes in patients’ brains could ‘change the landscape’ of future treatment, according to researchers.
It has already performed so well at early-stage trials involving people living with the disease in the United States that scientists are now in talks aimed at leapfrogging the usual second stage and fast-tracking it for larger trials.
Pharmaceutical firm Biogen, which developed the drug, called aduncanumab, wants to recruit at least 1,000 patients for tests by the end of the year.
Read all about it HERE
Alzheimer; News from the web:
A new large study by the Mayo clinic points at Tau being the dominant factor in causing Alzheimer. This research will be very beneficial in finding new ways for both prevention and treatment.
Read all about it HERE